KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced that on December 29, 2015, it filed a voluntary petition for bankruptcy protection ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE